How Adverse Events From Herbal Products Get Reported

Serious problems with herbal products surface slowly, and usually through case reports rather than through trials. The reasons are structural, and they mean the known risks understate the actual ones.

Why reporting is sparse

People do not classify herbal preparations as medicines, so they often do not mention them when asked what they are taking.

Clinicians frequently do not ask specifically, and a general question about medication rarely prompts a patient to list a traditional formula or a supplement.

Where a reaction does occur, attributing it to a herb is harder than attributing it to a prescribed drug, because the exposure is undocumented and the product is unstandardised.

How problems eventually surface

The usual route is a cluster of case reports describing a similar injury, most often liver damage, following use of a particular preparation.

Specialist registries for drug-induced liver injury have been important here, because the liver is where many herbal reactions present and the pattern is recognisable.

Once a signal exists, investigators can look back, test remaining product, check for adulteration and establish whether the association holds.

The identification problem

Attribution requires knowing what was consumed, and multi-ingredient formulas make that difficult even when the packet is available for testing.

Adulteration complicates it further, since products have been found containing undeclared pharmaceuticals, and the reaction may be to something not on the label.

Contamination with heavy metals or pesticide residue is another route, and this is not detectable by any inspection a consumer can perform.

Interactions are the least visible risk

Herbs that affect drug-metabolising enzymes can raise or lower blood levels of prescribed medicines, and the resulting harm appears as a failure of the drug rather than a reaction to the herb.

A transplant rejection or a bleeding episode looks like a problem with the prescription, and the herbal contribution may never be identified.

This is why the standard advice is to tell a doctor and pharmacist about every supplement and traditional preparation, particularly before surgery.

What an individual can do

Keeping the packaging, recording what was taken and when, and reporting a suspected reaction to the relevant national regulator all contribute to the signal.

Regulators in several countries operate reporting systems that accept submissions from the public as well as from clinicians.

Stopping the product and seeking medical assessment comes first, and jaundice, dark urine, severe fatigue or abdominal pain warrant urgent attention rather than watchful waiting.